Results 21 to 30 of about 5,424,062 (188)

New Method of Calculating the Excess Amount of Soft Tissues of the Orbit in Patients with Endocrine Ophthalmopathy when Planning Operations

open access: yesOftalʹmologiâ, 2019
Objective. Improving the efficiency of the operation of orbit decompression in patients with endocrine ophthalmopathy through the development of a new method for calculating an excess volume of soft tissues of the orbit. Patients and methods.
D. V. Davydov   +4 more
doaj   +1 more source

A Genomic Point Mutation in the Extracellular Domain of the Thyrotropin Receptor in Patients with Graves’ Ophthalmopathy [PDF]

open access: yes, 1994
Orbital and pretibial fibroblasts are targets of autoimmune attack in Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD). The fibroblast autoantigen involved in these peripheral manifestations of Graves' disease and the reason for the association
Sarkar, Gobinda   +4 more
core   +1 more source

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy

open access: yesThyroid Research, 2019
Background Treatment of moderate to severe Graves’ orbitopathy (GO) is based mainly on intravenous pulses of methylprednisolone. High doses of methylprednisolone can exert several adverse effects, some of which might be life-threatening. The objective of
Dorota Walasik-Szemplińska   +2 more
doaj   +1 more source

Comparison of Thyroid Size-Specific Radioiodine Dose and New Modified Dose Calculation in the Treatment of Graves’ Disease [PDF]

open access: yesEndocrinology and Metabolism
Background Previous studies of fixed-dose radioiodine therapy (RIT) for Graves’ disease (GD) have utilized a variety of techniques and reported differing success rates.
Alisara Wongsuttilert   +3 more
doaj   +1 more source

Can propylthiouracil induce autoimmune-related immunotoxicity? [PDF]

open access: yesVojnosanitetski Pregled, 2022
Introduction. The use of propylthiouracil can be associated with mild adverse reactions, but severe complications such as agranulocytosis and vasculitis can also be seen.
Bajkin Ivana   +4 more
doaj   +1 more source

Orbital lymphoma associated with Graves’ disease: A case report [PDF]

open access: yesVojnosanitetski Pregled, 2014
Introduction. The presence of bilateral exophthalmos and palpebral, periorbital edema associated with hyperthyroidism is most often considered as an initial sign of Graves’ ophthalmopathy.
Hajduković Zoran   +4 more
doaj   +1 more source

The preoperative thyroid function and perioperative course in patients with Graves' disease [PDF]

open access: yes, 2020
Graves' disease is an autoimmune disorder that induces increase in thyroid hormone production and release. Although euthyroid should be desirable to ensure a safe operation, some patients still undergo thyroidectomy with hyperthyroidism.
Kuba, Sayaka   +7 more
core  

Hypothyroid Graves’ Ophthalmopathy: Report of Two Cases

open access: yesEndocrinology Research and Practice, 2007
Graves’ disease is an autoimmune disorder of the thyroid gland. Ophthalmopathy is the most common peripheral manifestation of Graves’ disease. It is a very rare condition that a Graves’ patient presents with spontaneous hypothyroidism.
Barış Akıncı   +2 more
doaj   +2 more sources

Cancer and Mortality Risks of Graves’ Disease in South Korea Based on National Data from 2010 to 2019

open access: yesClinical Epidemiology, 2023
Young Ju Choi,1 Kyungdo Han,2 Won Kyoung Cho,3 Min Ho Jung,1 Byung-Kyu Suh4 1Department of Pediatrics, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; 2Department of Statistics and Actuarial ...
Choi YJ, Han K, Cho WK, Jung MH, Suh BK
doaj  

Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy [PDF]

open access: yesEndocrinology and Metabolism, 2019
BackgroundGraves' disease (GD) is an autoimmune thyroid disorder caused by antibodies stimulating the thyrotropin (TSH) receptor. TSH receptor antibody (TRAb) measurement is useful for predicting GD relapse after antithyroid drug (ATD) treatment. However,
Yun Mi Choi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy